CBR-2198

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCBR-2198
Drug Alias Nameantibacterial (Cumbre Pharmaceuticals Inc)CBR-2198
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGastroenteritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCumbre Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCumbre Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsGastroenteritis

Other Information

ATC CodeN/A
Related LinksN/A